REITHERA

🎓  𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻, 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵, 𝗮𝗻𝗱 𝗰𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻: 𝗼𝘂𝗿 𝘁𝗮𝗹𝗲𝗻𝘁𝘀 𝗶𝗻 𝗮𝗰𝘁𝗶𝗼𝗻!🔬 We are proud to celebrate the achievements of two of our brilliant researchers, who are actively contributing to scientific advancement through impactful projects. ✅ Romina Scala, our scientist and a PhD student within the industrial doctorate program of the University "G. d'Annunzio" Chieti-Pescara, recently participated in the PhD Day. During the event, Romina presented a poster on her research, developed in collaboration with Professor Gianluca Sala. Her project focuses on the use of oncolytic adenoviruses as vectors to encode antitumor agents, opening new avenues in cancer treatment. ✅ Our colleague Gianluigi De Benedetto just took part in the prestigious ddPCR World 2024, where he delivered a talk titled: “E1A Gene Copies Quantitation in Adenovirus Vectors Producers Cell Lines by Multiplex ddPCR”. His presentation highlighted new methodologies to optimize the production of adenoviral vectors, a crucial step in developing advanced therapies. 💡 These achievements reflect ReiThera's commitment to scientific research, training new talents, and collaborating with universities. We are proud to support our researchers in their journey, contributing together to the progress of medicine and biotechnology. 👏 Congratulations to Romina and Gianluigi for these outstanding milestones! #Research #Innovation #Biotechnology #ReiThera #PhD #ddPCRWorld2024 #Adenoviruses #OncolyticViruses

Stiamo #assumendo per un ruolo di “PD Scientist” a Greater Rome Metropolitan Area. Candidati subito o condividi questo post con la tua rete.

🌍  𝗘𝘅𝗰𝗶𝘁𝗶𝗻𝗴 𝗡𝗲𝘄𝘀: 𝗔 𝗡𝗲𝘄 𝗖𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻 𝘄𝗶𝘁𝗵 𝗙𝗼𝗼𝗿𝗯𝗮𝗻 𝗳𝗼𝗿 𝗮 𝗚𝗿𝗲𝗲𝗻𝗲𝗿 𝗙𝘂𝘁𝘂𝗿𝗲 🌱 We’re thrilled to announce that ReiThera has partnered with Foorban to bring a fresh, eco-conscious approach to our company’s food services. This collaboration reflects our ongoing commitment to sustainability, as we move towards greener, more environmentally-friendly practices in everything we do. 🌿 As part of this new initiative, we are making impactful changes: ♻️ Transitioning to glass containers, eliminating plastic waste in our food services. 🍽 Partnering with Foorban, whose focus on quality and sustainability aligns perfectly with our vision. 🌍 Reducing our environmental footprint, with each step bringing us closer to zero-waste goals. At ReiThera, we’re not just committed to innovative science, but also to nurturing a healthier planet for future generations. Stay tuned as we continue to introduce more green initiatives and work towards a fully sustainable operation.

Oggi l’Assessore allo Sviluppo Economico della Regione Lazio, Roberta Angelilli, insieme al suo team, ha visitato i laboratori e le strutture avanzate di Reithera. Queste visite rivestono un ruolo fondamentale per la nostra azienda perché rafforzano il legame tra le istituzioni e le realtà industriali del territorio, favorendo dialoghi diretti e un confronto sui progetti e sulle necessità del settore. Reithera ringrazia l’Assessore e il suo team per la visita e l’attenzione dimostrata verso il nostro lavoro: il supporto delle istituzioni è fondamentale per continuare a innovare e crescere insieme, contribuendo allo sviluppo scientifico e tecnologico della Regione Lazio. ... Today, the Lazio Region's Economic Development Councillor, Roberta Angelilli, along with her team, visited Reithera’s laboratories and advanced facilities. These visits play a fundamental role for our company as they strengthen the connection between institutions and the region’s industrial enterprises, fostering direct dialogue and discussions on projects and sector needs. Reithera thanks the Councillor and her team for their visit and for the attention given to our work: institutional support is essential to continue innovating and growing together, contributing to the scientific and technological development of the Lazio Region.

🌟 𝗖𝗲𝗹𝗹 & 𝗚𝗲𝗻𝗲 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 𝟮𝟬𝟮𝟰! 🌟 We’re proud that Michela Gentile, PhD has represented 𝗥𝗲𝗶𝗧𝗵𝗲𝗿𝗮, contributing with her expertise in viral vector manufacturing to this important event. Participating in conferences like this is key for our company, allowing us to share insights and connect with other leaders in the biotech space. Engagements like these not only showcase our innovations but also open doors for collaboration, strengthening our impact in advancing gene-based therapies. We’re proud to be part of such a dynamic community, pushing the boundaries of what’s possible in healthcare! 💼🌱 #CellAndGene2024 #ReiThera #BiotechInnovation #GeneTherapy #Healthcare

🌍 𝗥𝗲𝗶𝗧𝗵𝗲𝗿𝗮 𝗶𝗻 𝗔𝗰𝘁𝗶𝗼𝗻: 𝗝𝗼𝗶𝗻𝗶𝗻𝗴 𝗙𝗼𝗿𝗰𝗲𝘀 𝘁𝗼 𝗖𝗼𝗺𝗯𝗮𝘁 𝗠𝗮𝗿𝗯𝘂𝗿𝗴 𝗩𝗶𝗿𝘂𝘀 🌍 We’ can announce ReiThera's continued partnership with the Rwandan government and Sabin Vaccine Institute in addressing the Marburg virus outbreak. In response to this urgent health crisis: 𝗥𝗮𝗽𝗶𝗱 𝗗𝗲𝗽𝗹𝗼𝘆𝗺𝗲𝗻𝘁: ReiThera has produced and delivered 1,000 additional investigational vaccine doses for a new clinical trial in Rwanda, targeting high-risk populations. 𝗦𝘂𝗽𝗽𝗼𝗿𝘁 𝗳𝗼𝗿 𝗙𝗿𝗼𝗻𝘁𝗹𝗶𝗻𝗲 𝗪𝗼𝗿𝗸𝗲𝗿𝘀: To date, over 2,700 doses have been provided, and more than 1,500 frontline healthcare workers vaccinated. 𝗚𝗹𝗼𝗯𝗮𝗹 𝗛𝗲𝗮𝗹𝘁𝗵 𝗖𝗼𝗺𝗺𝗶𝘁𝗺𝗲𝗻𝘁:“This swift response underscores our dedication to deliver advanced biotech solutions when they’re needed most,” shared CEO Stefano Colloca, acknowledging the outstanding efforts of ReiThera’s 𝗤𝗔 𝗮𝗻𝗱 𝗣&𝗟 𝘁𝗲𝗮𝗺𝘀. As needs evolve, ReiThera is prepared to scale up production to ensure ongoing vaccine support in Rwanda’s fight against Marburg. Read our press release at: https://lnkd.in/dMRX3nrE #GlobalHealth #Biotech #VaccineInnovation #MarburgVirus #ReiThera

🚀 𝗣𝗿𝗼𝗴𝗿𝗲𝘀𝘀 𝗶𝗻 𝘁𝗵𝗲 𝗳𝗶𝗴𝗵𝘁 𝗮𝗴𝗮𝗶𝗻𝘀𝘁 𝗠𝗮𝗿𝗯𝘂𝗿𝗴! We are pleased to share that an additional 1,000 doses of the investigational #Marburg vaccine are on their way to #Rwanda, supporting a new randomized clinical trial arm of our ongoing study. Thanks to 𝗥𝗲𝗶𝗧𝗵𝗲𝗿𝗮, this shipment brings our total to over 2,700 doses delivered to address one of the largest recorded Marburg outbreaks declared on September 27. The updated trial protocol will evaluate safety, immunogenicity, and efficacy, focusing on high-risk individuals. Participants will receive their doses in a staggered manner, with half getting the vaccine immediately and the other half after 21 days, aligning with the disease's incubation period. To date, over 1,600 doses have been administered, primarily to frontline health workers, with our first shipment arriving in Kigali just 9 days after the outbreak was declared. With no approved vaccines or treatments for Marburg virus disease, our collaborative efforts are vital in this response. Together, we are working to make a difference in public health! 💉🌍 Sabin Vaccine Institute #VaccinesWork #PublicHealth #Reithera

🌍 𝗘𝘅𝗰𝗶𝘁𝗲𝗱 𝘁𝗼 𝘀𝗵𝗮𝗿𝗲 𝘁𝗵𝗮𝘁 𝗥𝗲𝗶𝘁𝗵𝗲𝗿𝗮 𝗽𝗮𝗿𝘁𝗶𝗰𝗶𝗽𝗮𝘁𝗲𝗱 𝗶𝗻 𝘁𝗵𝗲 𝗪𝗼𝗿𝗹𝗱 𝗩𝗮𝗰𝗰𝗶𝗻𝗲 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 𝗘𝘂𝗿𝗼𝗽𝗲! Our presence at this prestigious event allowed us to engage with industry leaders, showcase our innovative research, and explore new collaborations in the field of vaccine development. A special thank you to Federico Napolitano and Alessia Noto for representing 𝗥𝗲𝗶𝗧𝗵𝗲𝗿𝗮 with such passion and expertise. Your contributions are invaluable to our mission of advancing global health solutions. Together, we are making strides in addressing pressing health challenges. Here’s to forging stronger connections and driving impactful initiatives! #WorldVaccineCongress #Vaccines #Reithera #GlobalHealth #Collaboration

🚀𝐏𝐫𝐞𝐬𝐬 𝐑𝐞𝐥𝐞𝐚𝐬𝐞: 𝐄𝐱𝐜𝐢𝐭𝐢𝐧𝐠 𝐍𝐞𝐰𝐬 𝐢𝐧 𝐆𝐞𝐧𝐞 𝐓𝐡𝐞𝐫𝐚𝐩𝐲! 🚀 We're thrilled to share that 𝐑𝐞𝐢𝐓𝐡𝐞𝐫𝐚 has successfully manufactured and released the Drug Substance and Drug Product for AAVantgarde Bio groundbreaking 𝐋𝐔𝐂𝐄-𝟏 𝐭𝐫𝐢𝐚𝐥, which aims to treat Usher Syndrome Type 1B through the innovative AAVB-081 gene therapy. This First-in-Human trial represents a significant advancement in gene therapy, utilizing a proprietary dual-AAV platform to deliver the large MYO7A gene directly to patients suffering from retinitis pigmentosa. With approximately 20,000 individuals affected in the U.S. and E.U., this research holds the potential to transform lives. We are proud to collaborate with AAVantgarde, a spin-off of Telethon Institute for Genetics and Medicine (TIGEM) on this project. Our team’s expertise in GMP manufacturing and quality control has been essential in bringing this innovative treatment closer to those in need. As we push the boundaries of biotechnology, we remain committed to advancing medical science for the benefit of patients around the world. Congratulations to AAVantgarde Bio on dosing the first subject in the LUCE-1 trial! Let’s continue to pave the way for groundbreaking advancements in healthcare together. 💡 Read our Press Release at: https://lnkd.in/dtPvdiYS #GeneTherapy #UsherSyndrome #Biotechnology #Collaboration #Innovation #Healthcare #ReiThera #AAVantgarde

🌍✨ 𝗥𝗲𝗳𝗹𝗲𝗰𝘁𝗶𝗻𝗴 𝗼𝗻 𝗮𝗻 𝗶𝗻𝘀𝗽𝗶𝗿𝗶𝗻𝗴 𝗘𝗦𝗚𝗖𝗧 𝟮𝟬𝟮𝟰 𝗲𝘅𝗽𝗲𝗿𝗶𝗲𝗻𝗰𝗲! ✨🌍 As we return from an incredible week at #ESGCT2024, our hearts and minds are brimming with gratitude and excitement. Events like these remind us why we’re here—to connect, to share, and to innovate alongside some of the most passionate, driven professionals in our field. One of the true highlights? 𝗧𝗵𝗲 𝗵𝘂𝗺𝗮𝗻 𝘀𝗶𝗱𝗲 𝗼𝗳 𝗘𝗦𝗚𝗖𝗧. The moments spent in deep discussion, laughing over shared challenges, exchanging fresh perspectives, and sparking ideas for a healthier, safer world. Each handshake and conversation was a reminder of the power of collaboration and how, together, we push the boundaries of science to create meaningful impact. To everyone we had the pleasure of meeting, thank you for your insights, your stories, and your vision. Your dedication fuels us at ReiThera, reaffirming our mission to bring transformative therapies to life. 🌱💡 Looking forward to future collaborations and continuing the conversations we began here. 𝗨𝗻𝘁𝗶𝗹 𝗻𝗲𝘅𝘁 𝘁𝗶𝗺𝗲, 𝗘𝗦𝗚𝗖𝗧! #ESGCT #ReiThera #ConnectingForHealth #InnovationThroughCollaboration #ThankYou